In contrast, SRCAP variants upstream of exon 33 have been linked to non-FLHS SRCAP-related NDD, presenting with distinct DNAm profiles and an alternative set of phenotypes, including behavioral, psychiatric, and musculoskeletal problems as well as hypotonia (Rots et al., 2021). This evidence concerns the gene SRCAP and Neurodevelopmental delay.